BPC-157 Max can be used during or after an advanced supplementation cycle to support tissue health and accelerate recovery
A strong letter of medical necessity should include: your BMI history over at least 12 months, documentation of weight-related comorbidities (hypertension, type 2 diabetes or prediabetes, dyslipidemia, sleep apnea), prior weight-loss attempts and their outcomes, the specific clinical trial data supporting the requested medication, and a statement that the medication is medically necessary (not cosmetic)
GLP-1-based therapies for the treatment of resistant hypertension in individuals with overweight or obesity: a review
This increased fluid in the bowel softens the stool, makes it easier to pass, and can also increase stool volume, stimulating a bowel movement
Furthermore, nociceptors were reported to release CGRP and inhibit the recruitment of neutrophils to the infection site and opsonophagocytic killing of Streptococcus pyogenes bacteria, evidencing that this neuropeptide can modulate immune function and host response to pathogens (124)
GLP-1 medications may affect kidney function slightly in some patients, making pre-existing renal disease an important consideration
